0001209191-20-054686.txt : 20201013 0001209191-20-054686.hdr.sgml : 20201013 20201013172250 ACCESSION NUMBER: 0001209191-20-054686 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201013 FILED AS OF DATE: 20201013 DATE AS OF CHANGE: 20201013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARMAR KUSH CENTRAL INDEX KEY: 0001664281 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39612 FILM NUMBER: 201237410 MAIL ADDRESS: STREET 1: C/O AUDENTES THERAPEUTICS, INC. STREET 2: 101 MONTGOMERY ST., SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 5:01 Acquisition Corp. CENTRAL INDEX KEY: 0001823465 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 852790755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 SECOND STREET, SUITE 350 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-993-8570 MAIL ADDRESS: STREET 1: 501 SECOND STREET, SUITE 350 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-13 0 0001823465 5:01 Acquisition Corp. FVAM 0001664281 PARMAR KUSH C/O 5:01 ACQUISITION CORP. 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107 1 1 1 0 Co-CEO Class B Common Stock 0.00 Class A Common Stock 2300000 I See Footnote As described in the issuer's registration statement on Form S-1 (File No. 333-249036) under the heading "Description of Securities - Founder Shares and Private Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. The shares of Class B common stock owned by the Reporting Person includes up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the issuer's securities do not exercise in full their over-allotment option as described in the issuer's registration statement. Consists of shares held by 5:01 Acquisition, LLC ("Acquisition LLC") of which the Reporting Person is a manager. As such, the Reporting Person has voting and investment discretion and may be deemed to have beneficial ownership with respect to the shares of Class B Common Stock held by Acquisition LLC. The Reporting Person disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Exhibit 24 - Exhibit List - Power of Attorney /s/ Marianne Sarrazin, as Attorney-in-Fact 2020-10-13 EX-24.3_941338 2 poa.txt POA DOCUMENT AUTHORIZATION LETTER October 13, 2020 Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attn: Filing Desk To Whom It May Concern: By means of this letter I authorize Galya Blachman, Ph.D., Esq., Rebecca Lucia, CFA, Nicole Brookshire, Al Browne, Marianne Sarrazin and Nathan Jefferies, or any of them individually, to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock or derivative securities of 5:01 Acquisition Corp., the Company. Any of these individuals is accordingly authorized to sign any Form 3, Form 4, Form 5 or amendment thereto that I am required to file with the same effect as if I had signed them myself. This authorization shall remain in effect until revoked in writing by me. Yours truly, /s/ Kush M. Parmar LIMITED POWER OF ATTORNEY FOR SECTION 16(a) FILINGS Know all by these presents, that the undersigned hereby constitutes and appoints Galya Blachman, Ph.D., Esq., Rebecca Lucia, CFA, Nicole Brookshire, Al Browne, Marianne Sarrazin and Nathan Jefferies, signing individually, as the undersigneds true and lawful attorney-in-fact to: (1) Execute for and on behalf of the undersigned, in the undersigneds capacity as an officer, director and/or stockholder of 5:01 Acquisition Corp., the Company, Forms 3, 4, and 5 and amendments thereto in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, the Exchange Act, and the rules thereunder; (2) Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or amendment thereto and timely file such form with the United States Securities and Exchange Commission, the SEC, and any stock exchange or similar authority; and (3) Take any other action of any type whatsoever which, in the opinion of any such attorney-in-fact, may be necessary or desirable in connection with the foregoing authority, it being understood that the documents executed by and such attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-facts discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorney-in-facts, in serving in such capacity at the request of the undersigned, is not assuming, nor is any Company assuming, any of the undersigneds responsibilities to comply with Section 16 of the Exchange Act. This Limited Power of Attorney shall remain in full force and effect until the earlier to occur of (a) undersigned is no longer required to file Forms 3, 4, and 5 with respect to any securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company. This Limited Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of October 13, 2020. /s/ Kush M. Parmar